Fairfield Financial Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.1M | Sell |
30,358
-11,469
| -27% | -$792K | 0.73% | 32 |
|
|
2025
Q1 | $2.9M | Sell |
41,827
-1,977
| -5% | -$137K | 1.09% | 21 |
|
|
2024
Q4 | $3.77M | Sell |
43,804
-8,264
| -16% | -$711K | 1.33% | 18 |
|
|
2024
Q3 | $6.2M | Buy |
52,068
+3,605
| +7% | +$429K | 2.11% | 14 |
|
|
2024
Q2 | $6.92M | Buy |
+48,463
| New | +$6.92M | 2.04% | 14 |
|
|
2023
Q4 | $3.9M | Buy |
37,652
+7,245
| +24% | +$749K | 1.48% | 19 |
|
|
2023
Q3 | $2.77M | Buy |
30,407
+7,561
| +33% | +$688K | 1.16% | 24 |
|
|
2023
Q2 | $1.85M | Buy |
22,846
+7,380
| +48% | +$597K | 0.74% | 29 |
|
|
2023
Q1 | $1.22M | Buy |
15,466
+2,430
| +19% | +$192K | 0.53% | 31 |
|
|
2022
Q4 | $882K | Sell |
13,036
-792
| -6% | -$53.6K | 0.4% | 33 |
|
|
2022
Q3 | $689K | Buy |
13,828
+1,742
| +14% | +$86.8K | 0.33% | 37 |
|
|
2022
Q2 | $673K | Buy |
12,086
+5,080
| +73% | +$283K | 0.31% | 38 |
|
|
2022
Q1 | $389K | Buy |
+7,006
| New | +$389K | 0.14% | 55 |
|